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Abstract:
One of the most common causes of bone graft rejection is lack of a vascular network
connecting the graft to the existing native tissue – allowing for nutrient flow. Under current
grafting techniques, the existing blood vessel network in the patient slowly invades the implant
in order to supply the injured site with its necessary nutrients. The purpose of this research is to
determine if a synthetic bone graft with a stable microvascular network can be developed in
vitro. I hypothesize that the use of indirect angiogenic factors such as sonic hedgehog homolog
and hypoxia-inducible factor-1 in combination with the direct factor platelet-derived growth
factor can produce such a transplantable graft when in the presence of seeded poly-L-lactide
films. This project focuses on the use of these factors and co-culturing techniques to promote
cellular differentiation and proliferation into a vascularized network composed of bone tissue and
microvascular structures in the presence of a piezoelectric material.
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Introduction:
Bone grafts are amongst the most common orthopedic devices used worldwide to
augment bone regeneration. Synthetic long bone grafts are becoming an increasingly popular
alternative to the traditional autografts and allografts which require bone grafts from either the
patient or a suitable donor respectively. Drawbacks such as increased chance of infection, blood
loss, pain and limited supply of donor bone have started the transition from natural to synthetic
bone grafting techniques (1). Cases of failure with all types of bone grafts are often due to
inadequate angiogenesis when attempting to vascularly connect the proximal and distal ends of
the bone defect (1). When skeletal bone is damaged, an intact vascular network is necessary so
that nutrients and suitable growth factors carried by blood can reach the osteoblasts (bone cells)
attempting to repair the defect (2). When these nutrients and growth factors do not reach the
injury site, it can lead to failure of graft integration. Vascularization is especially important in
long bone repairs where the injury site is much larger. With grafts, the existing blood vessel
network in the patient slowly invades the implantation in order to supply the injured site with its
necessary nutrients (2, 3). In cases of long bone injury where the defect site is much larger, the
slow rate of cell proliferation into the graft to form the new vascular network is insufficient and
can ultimately lead to poor graft integration, function, and eventual graft failure (2).
The Botnar Research Group at the University of Oxford investigated the potential of
co-culturing endothelial cells, known for their ability to form blood vessels, with bone-marrow
derived fibroblasts. Their results suggest that fibroblast proliferation improved in the presence of
endothelial cells undergoing angiogenesis (4). Their results offer a promising future for
co-culturing endothelial and fibroblast cells to improve current bone-tissue engineering
techniques. Similar work was conducted by Dr. Ronald Unger as his lab co-cultured human
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osteoblasts with an endothelial cell line to determine the stability of the prevascular network
formed in vitro. They discovered that not only were microvascular networks established quicker
in the presence of osteoblasts, but also that these structures that formed were more stable and
longer lasting than microvascular networks formed in the absence of osteoblasts, as seen in their
control group (3).
Researchers at Johannes Gutenberg University have conducted in vitro osteogenesis
experimentation involving indirect angiogenic factors. However, this proceeding work did
analyze the impact of these factors on angiogenesis and osteogenesis in the presence of
piezoelectric nanofibers (5). These piezoelectric materials are a type of “smart” material that
generate an electrical gradient under applied force (6, 7). The films used in this experiment are
composed of fibers with diameters in the nanometer range.
Labs that have chosen to use indirect factors such as sonic hedgehog homolog (SHH) and
hypoxia-inducible factor 1 (HIF-1) in combination with the direct factor platelet-derived growth
factor (PDGF) produced positive results (5). These indirect factors have been shown to
encourage cellular secretion of several angiogenic factors that enable the cultured cells to
undergo tubulogenesis in vitro and form stable prevascular networks while avoiding the
formation of tumor-like masses and severe vascular leakage that characterizes excessive
production of vascular endothelial growth factor (VEGF) (2, 5, 8).
The cornerstone of my project is the incorporation of biodegradable piezoelectric
poly-L-lactide (PLLA) films, angiogenic principles, and preexisting osteogenic protocols to
compose a more effective and biocompatible synthetic bone graft. These PLLA films were
developed by the Nguyen Research Group through electrospinning techniques. What
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distinguishes our grafting scaffolds is their ability to be electrically stimulated by non-invasive
ultrasound without the implantation of batteries (Figure 1) (9). Bone is naturally piezoelectric in
nature, playing a key role in bone remodeling and the repair of fractures and dislocations. This
characteristic is what our films successfully replicate in their ability to create similar electrical
gradients when placed under ultrasound.
Collagen is one of the basic organic components of human bone and its parallel
alignment with non-piezoelectric, non-collagenous extracellular matrix materials induces bone
formation in vivo (10). Previous studies indicate that the origin of piezoelectricity is attributed to
the particular alignment of collagen molecules (11-13). These interspersed piezoelectric
microzones generate electrical gradients with areas of higher piezoelectricity in regions
composed of collagen fibrils and areas of less piezoelectricity, where non-collagenous
extracellular materials are present (11-13). Therefore, the measure of how well the nanofiber
scaffolds perform is in their ability to mimic this piezoelectric behavior of natural bone and
channel it into the promotion of cell differentiation and growth.
Other members of the Nguyen Research Group and myself have conducted stem cell
differentiation into osteoblasts using PLLA films as these films generate electrical charges on
either side when a mechanical stress is applied to them - promoting not only stem cell
differentiation into bone cells but also the repair and regeneration of the surrounding tissue (14).
This type of mechanical stress can be achieved using noninvasive ultrasonic treatment. The
PLLA films are firmly attached to the bottom of tissue culture plates via biocompatible silicone
glue. These plates are then suspended into an ultrasonic bath. The high crystallinity and long
degeneration time of our films allow them to retain their piezoelectric capabilities over the span
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of approximately one month, allowing proper time for the co-culturing of bone and blood vessel
tissue and the later implementation of the cultured film in vivo (9).
Current popular synthetic bone grafting materials often consist of hydrogels and synthetic
polymers in combination with chemical growth factors (15-17). However, these biomaterials
often release toxic chemicals into the surrounding tissues that can spread throughout the body
(15-17). As an alternative to these potentially toxic molecules, electrical stimulation has been
used to achieve the same results. However, current commercialized electrical stimulators require
non-degradable batteries to be implanted with them that have the potential to release toxic acids
into the surrounding tissues (18, 19). The surgery to implant these devices is often quite invasive
as it requires the implantation of not only the graft but batteries as well and potentially more
invasive surgery to remove the implant. The protocol I present for co-culturing bone and blood
vessel tissue in the presence of our biodegradable grafting material could produce an enhanced
synthetic bone graft for use in living organisms, potentially revolutionizing the field of
regenerative medicine.
My project had two major aims. The first aim was to establish piezoelectric PLLA films
as stable scaffolds for bone growth stimulation. The second aim was to determine the potential of
these PLLA films in combination with mouse fibroblasts and angiogenic factors to produce a
self-vascularizing and remotely controlled biodegradable synthetic bone graft. Aim one was
achieved in the laboratory through independent and team efforts to compensate for challenges
presented due to COVID-19. I personally conducted all in vitro experimentation and analysis
while other members of the Nguyen Research Group conducted all in vivo experimentation. My
independent work was later published alongside other associated work from the Nguyen
Research Group (9). I was unable to address the second aim through experimentation due to
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challenges presented from COVID-19. Instead, I formulated a recommended protocol for future
investigation of the potential for PLLA films seeded with fibroblasts and stem cells to improve
upon current synthetic bone grafting techniques.
Materials and Methods:
PLLA Films:
I prepared the PLLA nanofiber films via electrospinning where the PLLA solution was
ejected from a syringe onto an aluminum foil-wrapped drum rotating at speeds ranging from 300
to 3,000 rpm (Figure 2). As the rotation speed of the drum increased, the fiber alignment,
polymer crystallinity and piezoelectric property increased in a very tunable manner (19). Thus,
films prepared at 3000 rpm were highly piezoelectric whereas films prepared at 300 rpm were
significantly less piezoelectric. Films prepared at 1000 rpm were also analyzed to indicate the
progression of fiber alignment, crystallinity and piezoelectricity with increasing rotation speed
(Figure 3). The higher the electrospinning rate, the larger the surface charges on the nanofiber
film (9). For the purposes of this experiment, films were made under electrospinning rates of
300, 1000 and 3000 rpm and named non-piezoelectric, less piezoelectric and piezoelectric
respectively (9). With the assistance of other lab members, I annealed the formed fibrous mats at
160 ºC to get the final scaffold (9). I then cut this scaffold into 1/2’x1/2” pieces. Once fabricated,
other lab members utilized scanning electron microscopy to analyze the orientation of the PLLA
fibers. They then constructed force sensors made of the PLLA mat to ensure the ultrasound
receiving capability of the film before I sterilized the films using 70% ethanol and UV light and
placed them into well plates using biocompatible silicone glue (9).
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Sterilization was conducted until a laminar flow cell culture hood. I first soaked the films
in 70% ethanol for 30 minutes. After 30 minutes, the ethanol was removed and the soaked films
were placed under UV light for 20 minutes. After 20 minutes, I carefully flipped the films over
using sterile tweezers and then exposed them to UV light for an additional 20 minutes. After this,
a small amount of biocompatible silicone glue (KWIK-SIL produced by World Precision
instruments) was added to each well of a 6-well culture plate purchased from Thermo Scientific.
I then used a sterile spatula to smear the glue across the entire bottom of each well. Before the
glue dried, I placed a single sterile scaffold into each well using sterile tweezers, ensuring full
contact with the glue before the silicone cured. The biocompatible glue was used to ensure that
each scaffold was securely attached to its respective well. The silicone also prevented the
ultrasonic waves from reflecting off the walls of the polystyrene wells, dissipating in the process.
The plate was then set aside to allow the glue to fully dry prior to seeding cells onto the scaffolds
(9).
Bone Marrow Stem Cell (BMSC) Culture:
With the assistance of other laboratory members, BMSCs were harvested from the bone marrow
of 3-4-week-old transgenic mice containing DMP-RFP-mCherry and BSP-GFP-topaz fluorescent
reporter genes for imaging (9). The transgenic mice models were created by laboratory members
for the purpose of this experiment. Bone sialoprotein (BSP) and dentin matrix protein (DMP) are
reporter genes whose expression was quantified by me and other lab members to assess BMSC
differentiation (9). The bone marrow from all long bones of the mice were flushed by group
members with 10mL sterile 1X PBS using a 25 5/8-gauge syringe needle. Larger tissue pieces
were then broken up by passing the collected marrow through an 18 ½-gauge needle and then
plated at a titer of 10 x 10^6 cells/100 mm dish in proliferation media (9). The proliferation
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media was created by adding low glucose Dulbecco’s Modified Eagle Serum (DMEM), 10%
fetal bovine serum and 1% antibiotic solution containing 50% penicillin and 50% streptomycin.
All of these additional components were purchased from Gibco. I then expanded the cells in a
hypoxic incubation of 37 °C, 5% CO2, and 5% O2 to accelerate proliferation. After four days, I
changed the media to allow for hematopoietic cells to promote initial BMSC colony
development and to remove any non-adherent non-stromal cells. Once confluence was reached, I
collected the cells from the 100 mm dishes using accutase and then seeded onto the PLLA
nanofiber scaffolds in the prepared well plates (9).
Adipose Derived Stem Cell (ADSC) Culture:
ADSCs were purchased from iXCells Biotechnologies at a passage of 1. These cells were
received frozen, so I then thawed and plated the cells in a 100 mm dish with the previously
mentioned proliferation media. Cells were then expanded until passage 4, as per the received
iXCells protocol. I then passaged the cells every 5-6 days for expansion after the culture reached
80-90% confluence. I detached the cells at 80-90% confluence at passage 4 using
Trypsin/Ethylenediaminetetraacetic acid (EDTA) also purchased from Gibco. In order to expand
the cultures, I seeded ADSCs onto PLLA scaffolds at a density of 5 x 10^5 cells/scaffold under
proliferation media. After one day of proliferation media, I replaced the medium with an
osteogenic differentiation medium prepared by adding 50 μg/ml ascorbic acid and 10 mM
beta-glycerophosphate to the previously prepared proliferation medium. These cultures were
then left in the osteogenic differentiation medium for 24 hours before the daily ultrasonic
treatments began (9).
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Ultrasonic Treatment:
I performed ultrasonic treatments using a Branson 2800 CPX series sonication cleaning
bath set to 40 kHz. I conducted the treatments for 20 minutes daily over the course of 10 days.
To prevent non-sterile water from the bath from entering the wells and contaminating the culture
during the treatments, I reduced the amount of media in each well from 2 ml to 1 ml.
Furthermore, a standardized protocol was developed to seal the well plated prior to entering the
ultrasonic bath (9).
After the media in each well was reduced, I taped the top of the well plate to the bottom
on all 4 sides using labeling tape while inside the cell hood. I then removed the plate from the
hood and tightly encapsulated in three full layers of plastic wrap, making sure that the bottom of
the well plate was fully covered. I then sealed the plastic wrap using multiple layers of duct tape
manufactured by 3M. I wrapped the plate with 3 pieces of duct tape horizontally and an
additional 2 pieces vertically so that the entire bottom of the well plate was covered with the
tape. Finally, 4 small pieces of duct tape were used to cover the four edges of the plate to prevent
water from leaking through any corner gaps. I tore an additional piece of tape and centrally
placed it on the top of the encapsulated well plate to act as a tab that could be clamped so that
when the plate was suspended by it, the plate hung evenly and not tilted (9). The tab was used to
help suspend the plate into the sonication bath. Proper suspension was done by clamping an
alligator clip to the central duct tape tab. This alligator clamp was connected to a stationary
laboratory clamp and stand apparatus. The plate was suspended into the bath so that it was
halfway submerged into the water horizontally and then sonicated at 40 kHz for 20 minutes.
Acoustic pressure of 40 kHz was then introduced to the nanofiber scaffolds in the ultrasonic bath
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to stimulate the formation of surface charges on either side of the film, one positive side and one
negative. (Low frequency 40 kHz was used rather than a higher acoustic pressure of 1 MHz as it
was shown to exhibit less absorption by surrounding bodily tissues, consequently limiting the
potential damage the proposed treatment course could have on a living organism by overheating
the tissue) (9). Once completed, I removed the plate from the bath and the plastic wrap/duct tape
encapsulation was carefully removed with scissors. Any media that spilled out of the wells was
removed via aspiration and 2ml of fresh osteogenic media was pipetted into each well. I then
returned the plate to the incubator until the next ultrasonic treatment the following day (9).
Osteogenesis:
In vitro and in vivo experiments were conducted to study the osteogenic property of the
surface charges generated by the biodegradable nanofibers. I seeded ADSCs onto piezoelectric
(electrospun 3000 rpm), less piezoelectric (electrospun at 1000 rpm) and non-piezoelectric
(electrospun 300 rpm) and placed these films into ultrasonic baths at 40 KHz for 20 minutes/day
over the span of 10 days (9). I conducted this in vitro experimentation and analysis while in vivo
experimentation and analysis was conducted by other members of the Nguyen Research Group.
They accomplished this by creating a bone defect 3.5 mm in diameter on the calvaria bone of
mice and placing the nanofiber scaffold on top of the defect and suturing the covering skin
closed. For a proof-of-concept study, three mice were treated with the piezoelectric film and an
additional three mice served as the negative control sample by receiving non-piezoelectric films
(electrospun at 300 rpm) (9). The six mice were then all treated with the same ultrasound
consisting of 40KHz, 30 minutes daily over the course of 20 business days – not on weekends
(9). This ultrasound was directed at the site of graft implantation to mimic the direct ultrasonic
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treatment performed on the original well plates. Six weeks post-surgical implantation, the mice
were sacrificed for post-mortem analysis of the bone re-growth over the defect site utilizing
X-ray imaging and histological staining of the collected samples.
Bone Regeneration Assay:
After 10 days of ultrasonic treatment, each well plate culture was analyzed by me and
other members for osteogenic differentiation activity using Alkaline phosphatase (ALP) enzyme
quantification, polymerase chain reaction (PCR) for quantification of osteocalcin and osterix
activity, and alizarin red quantification. ALP and alizarin red assay data was normalized using
the total protein content measured using BCA assay purchased from Pierce. PCR data was
normalized using the housekeeping gene beta-actin (9).
BCA Assay:
Pierce BCA Protein Assay Kit was used to quantify total proteins content of each culture
and normalize these quantities.  Protein from each well was extracted using RIPA buffer and then
used for the BCA assay as well as ALP quantification. Kit protocol was followed to obtain
normalized results for total protein quantification (9).
ALP Quantification Assay:
After I removed media from the cultures, they were fixed in 70% ethanol at 4 ºC for one
hour. I then removed the ethanol and rinsed each well with dH2O. The alizarin red dye purchased
from EMD Milipore Corporation was then added by other group members to each well and
incubated at room temperature for 30 minutes. After 30 minutes, they rinsed the dye with dH2O
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and each well was viewed macroscopically and microscopically by other lab members and
myself for mineral formation that was stained red following the above treatment. We then
quantified the degree of red staining by destaining the red dye in cetylpyridinium chloride that
was purchased from Sigma Aldrich. The absorbance of this rinsed stain was then measured using
a UV-Vis spectrophotometer at 450 nm to determine the amount stained and then normalized by
total protein content (9).
PCR Quantification:
PCR quantification was performed by other lab members using the universal sybr green
master mix manufactured by Bio-rad. The primers used were osterix (forward sequence 5’-GGA
AAG GAG GCA CAA AGA A-3’) and osteocalcin (forward sequence 5’-CAA GCA GGA
GGG CAA TAA G-3’). The reverse primers (5’-GTC CAT TGG TGC TTG AGA A-3’ and
5’-CGT-CAC-AAG CAG GGT TAA G-3’ respectively) were also used, all four of these primers
and the housekeeping gene beta-actin, were all purchased from Integrated DNA technologies.
The forward sequence of beta-actin (5’-TCC TCC TGA GCG CAA GTA CTC T-3’) and the
reverse sequence (5’-CGG ACT CAT CGT ACT CGT GCT T-3’) were used (9).
They extracted RNA using Trizol reagent following the corresponding protocol for the
reagent provided by the manufacturer. After extraction, the RNA was preserved at -80 ºC until
quantification at which time the RNA was thawed, melted and converted to cDNA using the
iscript cDNA synthesis kit purchased from Bio-rad and following the given protocol of the
manufacturer. Following this protocol, the cDNA was mixed with the purchased primers and the
master mix was run through an RT-qPCR machine purchased from ABsystems to obtain the gene
expression values (9).
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Implantation Surgery:
Six transgenic NSG mice containing BSP-GFP-topaz fluorescent genes (Charles River,
MA) were used for the in vivo study conducted by other members of the Nguyen Research Group
They first anesthetized the mice with ketamine (Putney, KS)/xylecine (Akorn, IL) by members of
the Nguyen Research Group at UConn Health (9). They then created a 3.5 mm diameter calvarial
bone defect on the right side of the midline suture (9). A Dremel 10.8V drilling tool was then
used to cut through the bone while keeping the dura intact (Ref# 8000-02-F013, drill bit
(Meisinger, Germany) (9). A layer of collagen (Therma Fisher and prepared per manufacturer
protocol by adding sodium hydroxide and 10X PBS) was deposited on one side of the films to
ensure the films would stick to the defected calvarial bone and remain securely in place (9).
Three mice received PLLA films electrospun at 300 rpm and three mice were given PLLA films
electrospun at 3000 rpm. They then sutured the skin using 5-0 nylon sutures (Oasis) (9). Once
the mice regained consciousness post-surgery, they then injected an analgesic (Putney, KS) into
each mouse and again the following day to relieve the mice of any pain (9). Post-surgery, each
mouse was caged individually for the first two days and then 2 treated mice were caged together
for the remaining day. The ultrasonic treatments started 3 days after surgery (9). The surgical
procedure was approved by the institutional Animal Use Committee (Protocol # 101815-0421).
Histology:
Once the calvaria bone was harvested from the mice, they fixed the bone with 10%
neutral buffered formalin (purchased from Sigma) at 4 ºC overnight. They rinsed the bone with
1X PBS three times before being soaked in 30% sucrose (also purchased from Sigma) in dH2O
at 4 ºC until harvested samples became isotonic. Samples were then dried and embedded in
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Optimal Cutting Temperature Compound from Tissue-Tek. They accomplished this by
submerging the samples in 2-methylbutane that was chilled with dry ice. Embedded samples
were then cryosectioned to a thickness of 5 µm and then attached to cryotape (Cryofilm type II,
Section-Lab, CO) and UV-crosslinked onto glass slides for visualization. They then imaged these
sections under 10X objective to obtain images of mineral distribution (DIC). These sections were
then stained with nuclear fast red (Sigma) to visualize ALP active cells, Toluidine blue O
(Sigma) and DAPI (Mol Probes) to visualize cellular distribution. After this subsequent staining,
the sections were mounted with 30% glycerol in dH2O, and color imaged with a Zeiss Axio Scan
Z.1 automatic fluorescent slide scanning microscope under the 10X objective for visual analysis.
The BSP-GFP-topaz fluorescent genes already in the mice were used to visualize BSP
expressing cells in the cryosections as well (9).
Results:
Promotion of osteogenesis on piezoelectric nanofiber scaffolds:
Osteogenic activity was evaluated through a variety of means. In Figure 4a the
orientation of the experimental setup for the in vitro experimentation where the stem cells are
seeded onto the PLLA films with the ultrasonic waves reaching the cell wells from below. I then
stained these films and performed PCR quantitative analysis to both visualize and quantify bone
formation after treatment. I chose ALP assay and alizarin red assay to assess enzyme activity
indicative of bone formation and mineral formation respectively. PCR quantification of
osteocalcin and osteorix was performed by another member of the Nguyen Research Group as
these genes are responsible for promoting bone differentiation and growth. Films that were both
piezoelectric and treated with ultrasound showed significantly higher enzyme activity, mineral
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formation, and expression of the genes osteocalcin and osteorix (Figures 4b-f). These results
also represent the positive progression of bone formation with increased piezoelectricity and
exposure to ultrasonic waves. The degree of bone formation generally decreases when cells are
seeded on less piezoelectric scaffolds and to miniscule levels when seeded on non-piezoelectric
films and not treated with ultrasound.
Further analysis of in vitro osteogenic activity is portrayed in Figure 5, consisting of
schematic, microfluorescent, and graphical representations of BMSC differentiation. I collected
microscopic fluorescent images which I then observed under GFP channel (exposure time 100
ms) and cherry red channel (exposure time 1000 ms) to observe progressive expression of BSP
and DMP respectively. Figure 5b consists of these images taken of piezoelectric (3000 rpm),
less piezoelectric (1000 rpm), and non-piezoelectric (300 rpm) films after each receiving
identical ultrasound treatment after seeding. It also consists of images taken of piezoelectric and
non-piezoelectric films that received no ultrasonic treatment after seeding. These images indicate
that PLLA scaffolds electrospun at 3000 rpm are capable of promoting osteogenesis in the
seeded BMSCs when they underwent ultrasonic treatment (9). The fluorescent expressions of
these images were then quantified by other lab members using the two tailed T-test for statistical
analysis to derive the graphical comparisons (Figures 5c-d). The quantitative results suggest that
the piezoelectric PLLA films that also received ultrasound treatments exhibit significantly more
fluorescent intensity than films electrospun at the two lower rates or that received no ultrasound
treatment at all (significance level of 0.0001) (9). These results show that reporter genes
representing in vitro osteogenesis of BMSCs are activated and expressed in higher quantities
when BSCs are seeded and cultured on piezoelectric PLLA nanofiber scaffolds and given
consistent ultrasonic treatments when compared to the other samples.
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After obtaining positive results from in vitro experimentation, in vivo trials with
transgenic mice were performed by other members of the research group at UConn Health. The
x-ray and histological images composing Figure 6 were also taken by these other members.
Analysis of these images was conducted by me and other members of the laboratory group.
Films electrospun at 3000 rpm and 300 rpm were implanted to compare results of piezoelectric
and non-piezoelectric films in vivo when both groups are given identical ultrasound treatment.
Figure 6a is the x-rays (left column) and histological images (right column) of mice treated with
the piezoelectric nanofibers and 6b is composed of the x-rays and histological images of mice
treated with non-piezoelectric films. The lack of white arrows in the histological images of
Figure 6b is indicative of the lack of bone tissue formation in mice treated with
non-piezoelectric films and ultrasound. The presence of white arrows in the histological images
of 6a is indicative of bone tissue formation and the potential of our piezoelectric PLLA films to
serve as a plausible alternative to current synthetic bone grafting materials.
Figure 7 is composed of microscopic fluorescent images taken of the histological
sections seen in Figure 6. Figures 7a and b provide visual presentations of the ultrasonic
treatment performed on each of the six mice and the placement of the PLLA films on each.
Figure 7c consists of the aperture contrast images of the histological sections obtained after the
in vivo ultrasonic treatments. Figures 7d-g are microscopic fluorescent images of the same
histological sections but treated with ALP, DAPI and Toludene blue staining. The
BSP-GFP-topaz fluorescent genes already in the mice were used to visualize BSP expressing
cells (Figure 7e). These images show that PLLA films electrospun at 3000 rpm exhibit much
higher expressions of dentin matrix protein expression (DMP), bone sialoprotein expression
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(BSP), cell migration and bone formation and bone mineral formation compared to the group of
films spun at the lower speed (Figures 7c-g).
A plausible protocol for the co-culturing of human umbilical vein endothelial cells (HUVECs)
with ADSCs on PLLA piezoelectric scaffolds
I was unable to complete the second aim of this project due to complications from
COVID-19. Therefore, the suggested protocol below is what I would have completed under
normal circumstances and is what I recommend should be done with the results of aim one in
mind.
First, it is critical to promote the formation of tubular structures using HUVECs on
piezoelectric PLLA films. These cells should be seeded onto the PLLA films in the presence of a
growth medium that contain indirect cell growth factors to stimulate vessel formation and
maturation. Form the PLLA nanofiber films via electrospinning following the previously
mentioned protocol at 3000 rpm as the preliminary results indicate that this is the rate at which
the most piezoelectric film can be produced. Films should also be formed via electrospinning at
300 rpm as a negative control to support the hypothesis that the PLLA films are more
piezoelectric when electrospun at an increased rate and could better support cell differentiation
and growth (9). The PLLA solution should be ejected from a syringe onto an aluminum
foil-wrapped drum rotating at the desired 3000 rpm. Once annealed at 160 ºC, the films should
then be sterilized using 70% ethanol and UV light and then attached to well plates using
biocompatible silicone glue. There should be 12 wells in total, three of which should consist of
HUVECs seeded onto the piezoelectric films (electrospun at 3000 rpm) in the presence of the
growth factor. Another three wells with HUVECS seeded onto non-piezoelectric films
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(electrospun at 300 rpm) in the presence of the growth factor. Another three wells should have
non-piezoelectric films (spun at 300 rpm) seeded with HUVECs but not receive growth factors.
The last three wells will have HUVECs and receive growth factor but no PLLA film. All twelve
of these described wells should receive ultrasonic treatment to activate the piezoelectric
properties of the material that will stimulate angiogenesis in the HUVECs. The final twelve wells
should be established following the same parameters as the first nine wells except they will not
receive ultrasonic treatment to function as a negative control. The indirect growth factors
include: SHH, HIF-1, and angiopoietin 1 and 2 (Ang-1 and Ang-2) and the direct factor PDGF.
To characterize and quantify the angiogenic progress, I recommend immunofluorescence
analysis using antibody CD31 for platelet endothelial cell adhesion molecule-1 (PECAM- 1) to
check for green fluorescence. This analysis could determine the presence of microcapillary-like
structures formed by the endothelial cells (20). Areas that show sprouting of tubular structures
under the microscope should be photographed and analyzed using the Image J Software program.
Neutral red assays should also be conducted in the culture well-plates and these results be
analyzed with traditional spectrophotometry techniques to determine the concentration of viable
endothelial cells in the culture after culturing.
Once successful results are obtained from this individual culturing, coculturing of
HUVECs with ADSCs should then begin. The two cell types should be cultured in HUVEC-
conditioned medium to prevent this cell type from adopting osteoblast characteristics (21). Over
the course of 10 days, well-plates containing both cell types, HUVEC conducive medium and
1/2’x1/2” pieces of PLLA piezoelectric material should undergo ultrasonic treatments to activate
the piezoelectric properties of the material that can stimulate stem cell differentiation.
Immunofluorescence analysis with CD31 for PECAM-1 should be used as well as neutral red
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assays to stain for the total number of viable nuclei so that the osteoblasts can be seen in addition
to endothelial cells (20). To confirm that these additional nuclei are proliferating osteoblasts,
RT-PCR measurements of osteocalcin and osterix expression ought to be conducted. I predict
that these cocultures will successfully form stable vascularized structures at a faster rate when
seeded onto the piezoelectric PLLA films.
Discussion:
Remotely-controlled biodegradable piezoelectric films offer a minimally invasive and
low-frequency alternative to current commercial synthetic grafting techniques. The PLLA
nanofibers offer an extracellular matrix-like environment that promotes cell growth,
differentiation, and bone tissue regeneration while avoiding the undesired surgical removal of
grafts, increased likelihood of rejection or limited resources that are seen with alternative auto-
and allografts. PLLA nanofiber scaffolds are a feasible alternative to current synthetic bone
grafting techniques. They propose limited harm to patients receiving the macroscopic implants as
they do not require the toxic growth factors and non-biodegradable biomaterials in other
commercial grafts. PLLA films also do not require the use of attached batteries that could release
toxic chemicals damaging the graft, surrounding tissue, and the entire living organism.
All in vitro characterizations of osteogenesis with ADSCs and BMSCs described above
indicate that groups treated with piezoelectric scaffolds and ultrasonic treatment have
significantly greater osteogenic properties and capabilities than the other groups. In addition to
this, highly piezoelectric films with ultrasonic treatment exhibit higher charge expression in all
three assays than the less piezoelectric films with ultrasonic treatment and non-piezoelectric
films, supporting the hypothesis that increased surface charge increases osteogenic activity (9).
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While this nanofiber scaffold is biodegradable and biocompatible for tissue scaffolding,
properties of the PLLA films such as porosity and fiber size require additional research. The role
these two factors play in stem cell behavior have been studied by other labs (22-26). However,
the Nguyen Research Group has been working with a standard pore size and has not tried to
optimize these parameters for optimizing bone generation in vitro and in vivo. Further
investigation into the effects and potential importance of pore size and fiber size could aid in the
development of three-dimensional nanofiber structures which the current protocol does not
address.
Regarding future clinical applications of PLLA films, some challenges still exist.
Post-operative ultrasonic treatments can become very expensive, especially if needed for 10 days
or more. Additional research to enhance the material’s piezoelectric property so that less
stimulation is required for the same results would be ideal to decrease both time and cost of
treatment and increase accessibility of the new technology. I also recommend future exploration
of the use of growth factors like bone morphogenic protein (BMP) (27). BMP or metal
nanoparticles such as iron oxide or magnesium oxide could be applied in small portions to
reduce any acidic byproducts of PLLA degradation (27-30). These additives could further
enhance osteogenesis while still avoiding undesired side-effects of growth factors such as large
tumor-like masses that could further harm the host (9).
The working hypothesis is that PLLA film dissolution in vivo is non-toxic and
asymptomatic. However, this hypothesis remained untested. The rate of dissolution of the PLLA
films and how it’s controlled is also poorly understood at this time. Future experimentation
should involve treating the biodegradable films under different conditions such as temperature
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and polarizing electrical charges to help engineer the degradation rate in a tunable manner for
different defect sizes and severities.
In regard to the proposed protocol for coculturing HUVECs and ADSCs, there is plenty
of room for improvement as new technologies, staining procedures, and media components
become available with time and other scientific advancements. This protocol could also
potentially be improved with the incorporation of copper compounds in the PLLA mixture as it
is known to trigger angiogenesis of endothelial cells, specifically the CuSO4 complex (31).
Copper stimulation of microvascular structures is VEGF independent (32) which is critical to
prevent the excess accumulation of the factor due to its role in the formation of tumor-like
masses in the cultures. I recommend focusing on final copper sulfide concentrations of 5, 25, 50
and 100 µM for experimentation and narrowing down the ideal concentration after preliminary
experimentation. It’s hypothesized that the introduction of copper sulfide to the protocol will
promote minimal VEGF production indirectly to safely enhance wound healing (30-32).
Unfortunately, as the proposed protocol for coculturing has not been performed, the
functionality and maturation of the newly formed vessels is not understood at this time. In
addition to conducting and fine-tuning the protocol, further investigation will need to be done to
understand the results, histology alone is not sufficient to determine vessel perfusion and
stability. While the protocol might end in the development of numerous vascular structures, it is
not the overall number of vessels that is important but rather the number of functional vessels
and the amount of blood they can carry under various conditions.
Despite these drawbacks, the presented in vitro and in vivo results do indicate that our
piezoelectric films exhibit a great degree of cell migration and bone formation following
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ultrasound treatment (Figures 4-7). The piezoelectric nanofiber scaffolds have shown to be
superior to non-piezoelectric grafting alternatives with their ability to mimic the body’s natural
self-regenerating response by creating electrical gradients (13) and in their production of an
extracellular matrix-like environment that promotes cell growth, differentiation, and bone tissue
modeling (13, 20, 21). Our scaffold is not only biodegradable, but is also biocompatible,
battery-free and wirelessly-controlled (9). These films could greatly improve upon current
synthetic bone grafts and even for other tissues such as muscle, cartilage, skin, nerve, etc.
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Figures:
Figure 1. Biodegradable piezoelectric PLLA nanofiber mat for novel self-stimulated tissue
scaffold. a. Simplified explanation of implantation of PLLA nanofiber tissue-scaffolds to treat
long bone injury as a batter-free and biodegradable bone growth stimulator. b. Schematic
illustrating the parallel alignment of the nanofiber scaffold. c. Scanning electron microscopy
(SEM) image indicating the arrangements of the PLLA nanofibers after electrospinning at 3000
rpm with a red scale bar indicating 20 µm. This figure is modified from Das et al., 2020 (9).
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Figure 2. Measurement of the piezoelectric properties of the films under 40 kHz
ultrasound. a. Schematic of the setup used to measure the level of piezoelectricity of the
different scaffolds produced under the three different spinning rates. b. Voltage values collected
from an open circuit setup with the three PLLA films produced under different electrospun
speeds when 40 kHz ultrasonic acoustic waves are introduced. This figure is modified from Das
et al., 2020 (9).
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Figure 3. Characterization of the microstructure and piezoelectric performance of the
PLLA nanofiber mats. Schematic diagram of the electrospinning box used to fabricate our
scaffolds along with SEM images of scaffolds fabricated at different drum speeds with red scale
bars indicating 20 µm. This figure is modified from Das et al., 2020 (9).
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Figure 4. Osteogenic differentiation of stem cells, grown on the piezoelectric PLLA
nanofiber scaffold under applied ultrasound in vitro. a. Diagram demonstrating the seeding
of ADSCs onto the PLLA films and the direction from which the acoustic pressure of the
ultrasound reaches the plates. b. Graphical comparison of alkaline phosphatase (ALP) assay that
portrays enzyme activity indicative of bone formation. c and d. Qualitative and quantitative
comparison of mineral formation of the seeded cells measured using the alizarin red assay.
Yellow scale bars indicate 5 mm for comparison. e and f. Results from PCR quantitative
expressions of genes for bone differentiation and growth: osteocalcin and osteorix. (* represents
0.01 significance level, ** represents 0.001 significance level and *** represents 0.0001
significance level). This figure is modified from Das et al., 2020 (9).
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Figure 5. Osteogenic activity of reporter bone marrow stem cells (BMSCs) when grown on
the electrospun PLLA scaffolds with ultrasonic treatment. a. Simple schematic showing the
steps of differentiating bone marrow stem cells to mature bone cells. b. Microscopic fluorescent
images taken under GFP channel and cherry red channel with exposure times of 100 ms and
1000 ms respectively. These images are of the seeded stem cells on either piezoelectric or
non-piezoelectric scaffolds. c. Graphical comparison of fluorescent expression of osteoblasts
under GFP channel. d. Graphical comparison of fluorescent expression of osteocytes under red
cherry channel. This figure is modified from Das et al., 2020 (9).
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Figure 6. Healing of a critical sized (3.5 mm) calvaria defect covered by the piezoelectric
PLLA nanofiber scaffold under ultrasound treatment in vivo. a and b. X-ray images
corresponding to the cross-sectional histological images that were taken 6 weeks post-surgery
with scale bars representing 1 mm on the left images and 3 mm for the right images. a. X-ray
images taken of the three mice implanted with the piezoelectric nanofiber scaffolds constructed
from electrospinning at 3000 rpm. The areas in-between the white arrows correspond to the
newly forming bone tissue. b. X-ray images taken of the three mice implanted with
non-piezoelectric nanofiber scaffolds constructed from electrospinning at 300 rpm. The lack of
white arrows is indicative of the lack of bone tissue generation. This figure is modified from Das
et al., 2020 (9).
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Figure 7. Representative histology sections of the mouse calvaria bone showing details of
bone formation and cell migration into the defects for the groups of piezo-scaffold (3000
rpm) and non-piezoelectric scaffold (300 rpm) under identical ultrasonic treatments. a.
Schematic image of the in vivo experimentation of surgical implantation of our nanofibers
implanted onto defected mouse calvaria bone. b. Optical image of the surgical implantation of
our nanofiber scaffold implanted onto defected mouse calvaria bone. c. Microscopic fluorescent
images comparing the mineral formation over the bone defect between piezoelectric and
non-piezoelectric treated mice with aperture contrast. d. Images comparing the presence of ALP
producing cells on the piezoelectric and non-piezoelectric treated mice using vector blue ALP
staining. e. Microscopic fluorescent images comparing migration of BSP gene positive cells in
piezoelectric and non-piezoelectric treated mice. f. Microscopic fluorescent images comparing
overall cell migration of piezoelectric and non-piezoelectric treated mice with DAPI staining. g.
Microscopic optical images comparing overall bone formation between piezoelectric treated and
non-piezoelectric treated mice using Toludene blue staining. All scale bars are 1 mm. This figure
is modified from Das et al., 2020 (9).
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